CXCL5 and cancer: C-X-C motif chemokine ligand 5 (CXCL5) can bind to CXCR2 on cancer-associated fibroblasts (CAFs), thereby promoting the expression of PD-L1 and enhancing the therapeutic effectiveness of anti-PDL1 in CRC19.